Ludwig Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. American businessman Daniel K. Ludwig began to support cancer research with the establishment of the Ludwig Institute for Cancer Research in 1971. Today, the scientific efforts endowed through his resources have grown to encompass the Ludwig Institute and the Ludwig Centers and professorships at six U.S. institutions.

Leadership

Board of Directors

A Board of Directors has the ultimate responsibility for the Ludwig Institute for Cancer Research and the Ludwig Fund. Although they are separate Boards, the members are the same. Several board members also served as trustees of the Virginia and D.K. Ludwig Fund for Cancer Research, which oversaw the endowment of the six Ludwig Centers in the United States.

John L. Notter
Chair of the Board; Board Member, Conrad N. Hilton Foundation
Nancy E. Davidson, MD
Fred Hutchinson Cancer Research Center
Olivier Dunant
Law firm of Borel & Barbey
John D. Gordan III
Law firm of Morgan, Lewis & Bockius (retired)
Alexandra Johnson
Law firm of Bär & Karrer
Barbara S. Jones
Law firm of Bracewell LLP
Philip A. Pizzo, MD
Stanford University School of Medicine
Edward A. McDermott Jr.
President and Chief Executive Officer
Chi Van Dang, MD, PhD
Scientific Director
Scientific Advisory Committee

The Scientific Advisory Committee is a group of distinguished independent scientists and clinicians appointed by the Scientific Director of the Ludwig Institute to advise on emerging areas of cancer research and development that might help the Institute fulfill its mission. The group also assists in the scholarly review of Institute scientists.

History

Daniel K. Ludwig was born June 24, 1897, in South Haven, Michigan, USA. By the 1960s he was among the richest men in the world, with a self-made empire of some 200 companies. By the time of his death, he had pioneered the modern supertanker, participated in major oil and gas projects throughout the world, become a major investor and operator in the production of coal and other minerals, acquired and developed luxury hotels and other real estates, and developed a forest-products and agricultural enterprise that encompassed three million acres in the Amazon basin.

In 1971, he launched the Ludwig Institute for Cancer Research (he had to be persuaded strongly to allow his name to be used), endowing it with nearly all of his international holdings. That endowment is managed by the LICR Fund.

Upon his death in August 1992, Mr. Ludwig’s estate also provided for cancer research support at six leading U.S. academic institutions.

READ DANIEL LUDWIG’S FOUNDING STATEMENT

How we’re organized

The Ludwig Institute for Cancer Research Ltd is an international not-for-profit organization with a legacy of pioneering cancer discoveries that spans more than 45 years. The Institute provides its scientists with the resources and the flexibility to realize the life-changing potential of their work and see their discoveries advance human health. This philosophy, combined with robust translational programs, maximizes the potential of breakthrough discoveries to be more attractive for commercial development.

The Ludwig Institute conducts its own research and clinical trials, bridging the most basic questions of life to the most pressing needs of cancer care. Since its inception, the Institute has invested more than $1.8 billion of its own resources in cancer research, and has an endowment valued at $1.5 billion.

In addition, Ludwig Centers and Ludwig professorships have been established at six leading U.S. institutions. The Centers, created in 2006, operate independently of the Ludwig Institute but work collaboratively with each other and with the Institute at the forefront of cancer research. Each Center has a secure level of funding that generates more than $2 million a year in perpetuity. This funding empowers the Centers to attract the best and brightest scientists and provides unconstrained resources to tackle the most challenging projects for the benefit of cancer patients.

Funding

The LICR Fund

The LICR Fund Inc. is a US 501(c)3 organization that manages the assets of the Ludwig Institute for Cancer Research.

The LICR Fund’s investment goal is to provide sustainable core spending for the Ludwig Institute while maintaining the purchasing power of the Fund for future generations of scientists. The Fund, valued currently at $1.5 billion, is overseen by a Board of Directors, which determines investment policy and objectives, defines guidelines for the allocation of assets and—together with the Institute’s Investment Office—appoints and evaluates outside investment managers.

The Fund’s orientation is global and broadly diversified, with an investment portfolio incorporating a range of asset classes and strategies designed to achieve its risk-adjusted objectives.

The Virginia and D.K. Ludwig Fund

The Virginia and D.K. Ludwig Fund for Cancer Research endowed the Ludwig Centers under the terms of the will of Daniel Ludwig. Each Center is endowed, providing generous and secure funding for the indefinite future.

Careers

Ludwig is always hungry for creative scientific minds and brilliant people to help further our mission. Check this space regularly for the latest job openings at our locations around the world.

Ludwig Oxford vacancy: Research Integrity Manager
Oxford

Grade 7: £33,309 – £40,927 with a discretionary range to £44,706 per annum. Apply by 25th July 2022.

We are seeking to appoint a Research Integrity Manager to join the Ludwig Cancer Research Oxford Branch, in the Nuffield Department of Medicine.

You will have a key role in maintaining scientific integrity in our published research, including managing the archiving of original datasets supporting publications and carefully checking all original and processed data against the publication figures. You will assist in developing policies, SOPs and a training program to maintain high standards of research integrity, scientific record-keeping and good data management in the Branch, in furtherance of existing University and Departmental guidance and policy.

This would be an ideal first step for a post-doctoral researcher or equivalent wishing to pursue a career in research administration. There will be training and opportunities to further enhance your existing strengths in data management and to explore best practice in research integrity. We strongly encourage career development within the Branch, and you will be encouraged to actively contribute to Branch strategy alongside faculty and senior staff members.

It is essential that you hold a PhD (or close to completion) in a relevant life sciences field, along with experience in preparing scientific research papers. A strong understanding of good research practice and high levels of accuracy and attention to detail, especially with respect to scientific data, is also required. You will have a systematic, thorough, and well-organized approach to work, with the ability to work to deadlines and prioritize tasks. You will have excellent interpersonal and communication skills with the ability to interact equally effectively with senior academic staff, researchers and support staff within the University and the Ludwig Institute.

This position is offered full time / part time considered (26.25 hours/ 70% FTE) on a fixed term contract for 3 years in first instance and is funded by Ludwig.

Applications must be made online by 12 midday (UK time) on Monday 25th July 2022.

 

 

Go To Oxford Page    

See Full Job Posting    

Ludwig Oxford vacancy: Postdoctoral Research Scientist – Bioinformatics
Oxford
Grade 8: £42,149 – £50,296 with a discretionary range to £54,943 per annum. Apply by 25 July.
We are seeking to appoint a Postdoctoral Research Scientist to join the Ludwig Institute for Cancer Research.

You will participate in the Ludwig Cancer Research funded research program led by Skirmantas Kriaucionis, Benjamin Schuster-Böckler, Chunxiao Song, and Xin Lu and provide statistical analysis plans for studies while contributing to the overall planning of studies. You will be responsible for advising laboratory and other bio-statistical staff working on relevant projects and assisting others in their work where appropriate. You will conduct detailed analysis of datasets, as well as develop and tailor methodologies for analysis and data collection in collaboration with members of the research team. You will also contribute to manuscripts, presentations and other means of disseminating results and attend scientific seminars, meetings and training as appropriate while contributing ideas and communicating effectively with database experts and scientific programmers.

It is essential that you hold a PhD (or equivalent) in Biostatistics, Mathematics, Statistics, Computing, Mathematical Biology or a related subject. You will be able to demonstrate experience, ability and practical success in biostatistics or bioinformatics. You will have proficiency in the use of statistical programming languages and high-performance computing. You will be someone with a demonstrable ability to organise and prioritise work efficiently whilst delivering results to the required standard and to an agreed schedule.

Applications for this vacancy are to be made online and you will be required to upload a supporting statement and CV as part of your online application.  Your supporting statement must explain how you meet each of the selection criteria for the post using examples of your skills and experience.

This position is offered full time on a fixed term contract until 30 September 2026 and is funded by Ludwig.

Applications are to be made online by 12.00 noon (UK time) on Monday 25 July 2022.

Go To Oxford Page    

See Full Job Posting    

Assistant, Associate or Full Professor, Ludwig Princeton Branch – Cancer, immunity and metabolism
Princeton

Princeton University seeks applications for an assistant, associate or full professor to contribute to a major new initiative with biological foci on cancer, immunity, and metabolism at the Ludwig Princeton Branch. Candidate selected will be appointed to a tenured or tenure-track position in an academic department at Princeton appropriate for the candidate’s area of specialization and will also hold a corresponding membership in the Ludwig Institute for Cancer Research.

Responsibilities include teaching and service in accordance with the standards for the academic department in which the candidate is appointed, and research, including operation of a vibrant research group to benefit from both Princeton University and Ludwig Princeton Branch funding (with expectations to compete also for external funds). The research focus of the Ludwig Princeton Branch is cancer metabolism (including immune metabolism and tumor microenvironment), broadly defined to also encompass development of relevant physical, chemical, computational, and engineering technologies and exploration of relevant biological factors including diet and the microbiome. Applicants are expected to hold a PhD or MD, optionally with relevant additional research experience (industrial, postdoctoral, or as a faculty member) and a strong track record of research accomplishments. We value building a culturally diverse intellectual community; women and members of underrepresented groups are strongly encouraged to apply. Applicants should submit a description of research interests (typically 2 – 3 pages), curriculum vitae, a list of publications and contact information for three referees online at https://www.princeton.edu/acad-positions/position/26806.  For fullest consideration please apply by September 1, 2022.  Late applications may be reviewed up to December 1, 2022.

This position is subject to the University’s background check policy.

Go To Princeton Page    

See Full Job Posting    

Assistant, Associate or Full Professor, Ludwig Princeton Branch – Cancer and metabolism
Princeton

Princeton University seeks applications for an assistant, associate or full professor to contribute to a major new initiative at the interface between the physical and computational sciences and disease biology, with a particular focus on cancer and metabolism at the Ludwig Princeton Branch. Candidate selected will be appointed to a tenured or tenure-track position in an academic department at Princeton appropriate for the candidate’s area of specialization and will also hold a corresponding membership in the Ludwig Institute for Cancer Research.

Responsibilities include teaching, service (both in accordance with the standards for the academic department in which the candidate is appointed) and research, including operation of a vibrant research group to benefit from both Princeton University and Ludwig Princeton Branch funding (with expectations to compete also for external funds). Candidates are expected to devote a meaningful portion of their research effort to work that bridges between a hard science, computer science, or engineering discipline and an area of biology of relevance to the Ludwig Princeton Branch, such as cancer, metabolism, immunology or the microbiome. Applicants are expected to hold a PhD or MD, optionally with relevant additional research experience (industrial, postdoctoral, or as a faculty member) and a strong track record of research accomplishments. We value building a culturally diverse intellectual community; women and members of underrepresented groups are strongly encouraged to apply. Applicants should submit a description of research interests (typically 2 – 3 pages), curriculum vitae, a list of publications and contact information for three referees online at https://www.princeton.edu/acad-positions/position/26805.  For fullest consideration, please apply by September 1, 2022.  Late applications may be reviewed up to December 1, 2022.

This position is subject to the University’s background check policy.

 

Go To Princeton Page    

See Full Job Posting    

Ludwig Oxford vacancy: Senior Group Leader in Cancer Epigenetics
Oxford

Grade 10: £55,750 – £60,605 with a discretionary range to £70,579 per annum. Apply by 19th August 2022

We are seeking to recruit a Senior Group Leader with research interests in cancer epigenetics. As a Group Leader in Cancer Epigenetics, you will lead a significant research group at the Ludwig Institute for Cancer Research. This position benefits from substantial core funding which will enable you to build, develop and manage a successful research team. You will supplement this core funding with successful grant applications to enable you to further grow your group, develop a novel research program and produce measurable scientific output, including publications in high impact journals. As a recognized authority in the field of epigenetics, you will contribute to the strategic direction of the Ludwig Institute Oxford Branch and create productive collaborative relationships within the University and beyond.

It is essential that you hold a relevant PhD/DPhil with proven significant post-qualification research experience. The successful candidate will have a research proposal that is complementary to the Ludwig Institute’s research themes and aims in cancer epigenetics. You will be experienced in leading a successful and novel research program, as well as managing research staff and PhD students. A successful track record of attracting funding and managing budgets, as well as evidence of an established international publication record is crucial to the role.

Applications for this vacancy are to be made online and you will be required to upload a research proposal, supporting statement and CV as part of your online application.  Your supporting statement must explain how you meet each of the selection criteria for the post using examples of your skills and experience.

This position is offered full time on a fixed term contract for five years in the first instance and is funded by the Ludwig Core Award.

Applications must be made online by 12.00 noon (UK time) on 19th August 2022

Go To Oxford Page    

See Full Job Posting    

Contact

Baltimore

Ludwig Center at Johns Hopkins
1650 Orleans Street, Cancer Research Building, Room 590
Baltimore, Maryland, U.S. 21287

T 410 955 8878
F 410 955 0548

Boston Harvard

Ludwig Center at Harvard
450 Brookline Avenue
Boston, Massachusetts, U.S. 02215

T 617 632 3985
F 617 632 3408

Boston MIT

Ludwig Center at MIT
77 Massachusetts Avenue, 76-158
Cambridge, Massachusetts, U.S. 02139

T 617 258 5159
F 617 258 5213

Brussels

Ludwig Institute for Cancer Research, Brussels
Avenue Hippocrate 74, Bte B1.74.03
Brussels, BRU, BE, 1200
Belgium

T 32 2 764 7459

Chicago

Ludwig Center at the University of Chicago
5758 South Maryland Avenue MC 9006
Chicago, Illinois, U.S. 60637

T 773 702 0817
F 773 834 7233

Lausanne

Ludwig Institute for Cancer Research, Lausanne
Agora Research Center
Rue du Bugnon 25A, CH-1005 Lausanne

T (41) 21 545 10 77
F (41) 21 692 59 95

New York HQ

Ludwig Institute for Cancer Research
600 Third Avenue, 32nd floor
New York, New York, U.S. 10016

T (212) 450 1500
F (212) 450 1565

New York MSK

Ludwig Center at MSK
1275 York Avenue, Box 212
New York, New York, U.S. 10065

T 646 888 3165
F 646 422 0453

Oxford

Ludwig Institute for Cancer Research, Oxford
Nuffield Department of Clinical Medicine
Old Road Campus Research Building
off Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK

T +44 (0) 1865 617507

Princeton

Ludwig Institute for Cancer Research, Princeton
Princeton University
127 Frick Chemistry Laboratory
Princeton, NJ 08544

ludwigcancer@princeton.edu

T +1 (609) 258-2436

San Diego

Ludwig Institute for Cancer Research, San Diego
9500 Gilman Drive,
Cellular and Molecular Medicine East Building
La Jolla, California, U.S. 92093-0670

T 858 534 7802
F 858 534 7750

Stanford

Ludwig Center at Stanford
Lokey Stem Cell Research Building
265 Campus Dr., 3rd Floor
Stanford, California, U.S. 94305-5323

T 650 234 0675

Zurich

Ludwig Institute for Cancer Research
Stadelhoferstrasse 22
8001 Zurich, Switzerland

T (41) (0) 44 267 62 62

Baltimore
Boston Harvard
Boston MIT
Brussels
Chicago
Lausanne
New York HQ
New York MSK
Oxford
Princeton
San Diego
Stanford
Zurich
Founding statement

In creating this organization I have been guided by certain principles which throughout my life I have found to be highly effective. Success in any complex enterprise consists in bringing the best minds to bear on each problem, in providing the best resources possible, and in putting each concept into practice whenever and wherever the opportunities are most favorable. I believe firmly in the value of applying these principles in grappling with tasks as momentous as finding ways to relieve the human suffering caused by cancer.

Why should this undertaking be international? The rare vision and ability needed in the battle against cancer are not limited by frontiers, and the scientists who possess these gifts must be sought wherever they are to be found. Nor does cancer reveal itself in the same guise in every nation, but strikes different populations in different forms. Yet despite the growing necessity for concerted worldwide effort, I find no agency, which has both the truly international scope and the substantial resources, which I deem essential for a comprehensive attack on human cancer.

In my judgment the ultimate conquest of this frightful disease is not yet in sight, and the same view is held by most informed physicians and scientists in bio-medical research. In contrast to those who would yield to undue optimism, and who hope for too much from present programs. I am persuaded that eventual mastery of cancer will come only from intense and unremitting scientific exploration over many decades. This should not be hindered by the changing policies of governments and the vagaries of public interest. Accordingly it is my intention that the Institute shall be so structured as to ensure secure and continuing support for the attainment of its aims. The elimination of cancer will surely rank as one of man’s greatest and uncontroversial achievements. That day may be long delayed. How long we cannot tell. But I do not doubt that it will surely come.

D.K. Ludwig
December 17, 1974

Notice
?

You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?

Continue
Cancel